Tumor-specific biomarkers

Show results for

Unknown (3886)
Transcriptomics (614)
Genomics (513)
Proteomics (163)
Metabolomics (30)
Methylation profiling (27)
Clinical (20)
Other (20)
Genomic (6)
Multiomics (2)
Models (1)

Organisms

Homo sapiens (683)
Mus musculus (105)
Rattus norvegicus (15)
Danio rerio (5)
Drosophila melanogaster (3)
Canis lupus familiaris (3)
Daphnia magna (2)
Chlorocebus aethiops (2)
Bos taurus (2)
synthetic construct (2)
Vitis labrusca x Vitis vinifera (1)
groundwater metagenome (1)
Capra hircus (1)
Mytilus galloprovincialis (1)
Toxoplasma gondii (1)
Vitis vinifera (1)
Helicobacter pylori (1)
Cricetulus griseus (1)
Streptococcus pneumoniae (1)
Plasmodium falciparum (1)
Ateles geoffroyi (1)
Gorilla gorilla (1)
Lagothrix lagotricha (1)
Lemur catta (1)
Macaca mulatta (1)
Macaca nemestrina (1)
Pan paniscus (1)
Pan troglodytes (1)
Pongo pygmaeus (1)
Saguinus labiatus (1)

Organisms

Homo sapiens (289)
Mus musculus (40)
Canis lupus familiaris (2)
Chlorocebus aethiops (1)
human metagenome (1)

Repository

biostudies-arrayexpress (459)
ENA (396)
geo (282)
pride (78)
EGA (54)
MassIVE (35)
MetaboLights (28)
iProX (17)
jPOST (8)
dbGaP (6)
PanoramaPublic (5)
GPMDB (3)
GNPS (2)
BioModels (1)

Tissue

Cell culture (16)
Brain (10)
Epithelial cell (9)
Colon (8)
Blood plasma (6)
Liver (6)
Blood serum (5)
Lung (4)
Urine (3)
Vitreous humor (2)
Lymph node (2)
Bone marrow (2)
Skin (2)
Stomach (2)
Prostate gland (2)
Pancreas (2)
Urinary bladder (2)
Kidney (2)
Hepatocyte (2)
Mesonephric duct (1)
Lymphoma cell line (1)
Colon endothelium (1)
Glioma cell (1)
CT-26 cell (1)
Lung adenocarcinoma cell line (1)
Blood-lymph (1)
Bile duct (1)
Germ cell cancer cell (1)
Teratocarcinoma cell (1)
Prostate cancer cell (1)

Disease

Colorectal Neoplasms (11)
Glioblastoma (8)
Colon cancer (8)
Brain glioblastoma multiforme (5)
Malignant neoplasm of ovary (4)
Brain cancer (4)
Breast cancer (4)
Not Available (3)
Urinary bladder cancer (3)
Pancreatic cancer (3)
Prostate adenocarcinoma (3)
Retinoblastoma (3)
Melanoma (2)
Colorectal cancer (2)
Head and neck cancer (2)
Serrated colerectal carcinoma (1)
Post-stasis (1)
Apparently healthy (1)
Liposarcoma (1)
Rheumatoid arthritis (1)
Normal (1)
Locally advanced rectal cancer (1)
Normal (1)
Breast Neoplasms (1)
Pancreatic Neoplasms (1)
Carcinoma, Non-Small-Cell Lung (1)
Malignant neoplasm of colon (1)
Carcinoma (1)
Colorectal cancer (1)
Gastrointestinal Neoplasms (1)

Technology Type

Mass Spectrometry (78)
Shotgun proteomics (45)
Bottom-up proteomics (17)
Mass spectrometry (16)
Data-dependent acquisition (10)
Mass spectrometry assay (8)
NMR spectroscopy (5)
Affinity purification coupled with mass spectrometry proteomics (5)
Data-independent acquisition (5)
Top-down proteomics (3)
Illumina Genome Analyzer IIx, Illumina HiSeq 2000 (2)
Illumina HiSeq 2000 (2)
Illumina HiSeq 2000, ILLUMINA (2)
Gel-based experiment (2)
SWATH MS (2)
Illumina CytoSNP, Illumina HumanOmni2.5, ILLUMINA, Illumina 450k, Illumina HiSeq 2000 (1)
ILLUMINA, Illumina HiSeq 4000, Illumina MiSeq (1)
Illumina HiScanSQ, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2500 (1)
Illumina (1)
Illumina HiSeq 2000, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2000, Illumina Genome Analyzer II, ILLUMINA (1)
Illumina MiSeq (1)
Glycoproteomics (1)
Mass spectrometry imaging (1)
Immunopeptidomics (1)
All-ion fragmentation (1)

Instrument Platform

Q Exactive (19)
NextSeq 500 (4)
Orbitrap Fusion Lumos (4)
Illumina NovaSeq 6000 (3)
Illumina HiSeq 2000 (3)
Instrument (3)
Illumina HiSeq 2500 (2)
LTQ Orbitrap Velos (2)
Orbitrap Exploris 240 (2)
Orbitrap Eclipse (2)
LTQ Orbitrap (2)
Illumina Hybridization Oven (1)
Thermal cycler, Eppendorf ThermoMixer C (1)
Promega Maxwell RSC instrument (1)
Leica microtome, 1 mm biopsy punch (1)
QiaCube MDx (1)
G2565BA DNA microarray scanner (1)
Illumina protocol (1)
Illumina iScan System (1)
IScan Illumina (1)
None (1)
Hiseq2500 (1)
Illumina NovaSeq X (1)
None (1)
MS:1000490 (1)
LTQ Orbitrap XL ETD (1)
MS:1000031 (1)
Synapt MS (1)
Q-Exactive (1)
TripleTOF 6600 (1)

Publication Date

2014 (86)
2012 (80)
2010 (75)
2025 (73)
2013 (73)
2015 (55)
2026 (55)
2024 (51)
2016 (50)
2011 (47)
2023 (35)
2018 (35)
2022 (34)
2017 (28)
2009 (28)
2021 (24)
2019 (23)
2008 (23)
2020 (22)
2007 (7)
2005 (4)
2006 (2)

CHEBI ID

CHEBI:16737 (11)
CHEBI:16919 (11)
CHEBI:15428 (11)
CHEBI:15354 (10)
CHEBI:15891 (10)
CHEBI:17750 (9)
CHEBI:30769 (9)
CHEBI:18132 (8)
CHEBI:17268 (8)
CHEBI:18012 (8)
CHEBI:16704 (7)
CHEBI:18211 (7)
CHEBI:70959 (7)
CHEBI:48430 (7)
CHEBI:17368 (7)
CHEBI:16857 (7)
CHEBI:17191 (7)
CHEBI:78646 (7)
CHEBI:17596 (7)
CHEBI:78320 (7)
CHEBI:16449 (7)
CHEBI:35932 (6)
CHEBI:37084 (6)
CHEBI:17126 (6)
CHEBI:16811 (6)
CHEBI:15728 (6)
CHEBI:17768 (6)
CHEBI:27266 (6)
CHEBI:17568 (6)
CHEBI:27570 (6)

Metabolite Name

Creatinine (7)
Citrulline (6)
Taurine (6)
Glycine (6)
L-Glutamic acid (6)
Choline (6)
SM(d18:1/16:0) (5)
Valine (5)
Creatine (5)
N1-Methyl-2-pyridone-5-carboxamide (4)
SM(d18:1/24:1(15Z)) (4)
O-Tyrosine (4)
4-Methylcatechol (4)
Mannitol (4)
Pyroglutamic acid (4)
Glucose (4)
Hypoxanthine (4)
L-Threonine (4)
L-Histidine (4)
Pantothenic acid (4)
L-Arginine (4)
SM(d18:1/14:0) (4)
Guanosine (4)
Inosine (4)
Uridine (4)
L-Isoleucine (4)
PC(22:2(13Z,16Z)/16:1(9Z)) (3)
PC(16:0/18:2(9Z,12Z)) (3)
Ganoderiol C (3)
Leonuriside A (3)

First Public Date

2014 (76)
2025 (60)
2026 (52)
2024 (46)
2018 (30)
2023 (19)
2021 (19)
2022 (18)
2020 (17)
2015 (15)
2017 (14)
2019 (12)
2016 (9)
2013 (9)

Modelling Approach

Other (1)

Study status

Recruiting (8)
Not provided (4)
Completed (4)
Terminated (2)
Suspended (1)
Active, not recruiting (1)

Lab affiliation

UHN (3)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada. (2)
Utrecht University (2)
Ist. G. Gaslini (2)
The Guomics Laboratory for Proteome Complexity Science, School of Medicine, School of Life Sciences, Westlake University，Shilongshan Road No.18, Cloud Town, Xihu District, Hangzhou, Zhejiang, China. (1)
Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) (1)
Department of Life Sciences, University of Mdoena and Reggio Emilia (1)
Institute for Molecular Medicine I Medical Faculty Heinrich-Heine-University Duesseldorf Universitaetsstrasse 1 40225 Duesseldorf Germany (1)
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel (1)
Department of Clinical Laboratory, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University (1)
Professor, Department of Molecular Genetics, University of Toronto, Canada Scientific Director, SPARC BioCentre, Hospital for Sick Children (Sickkids), Toronto, Canada (1)
IUSM Center for Proteome Analysis, Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN (1)
Head of Proteomics Unit Spanish National Cancer Research Centre (CNIO) Address: Melchor Fernández Almagro, 3. 28029 Madrid. SPAIN Phone: +34 917 328 000 Ext. 3110 (1)
Papé Family Pediatric Research Institute Oregon Health & Science University 3181 SW Sam Jackson Park Road Portland, Oregon 97239, USA (1)
Department of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India (1)
Nanobio Measurement Group, Division of Biomedical Metrology, Korea Research Institute of Standards and Science (KRISS), Daejeon 34113, Republic of Korea (1)
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India (1)
Department of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China (1)
Uppsala Universtiy Dept. Chemistry-BMC Analytical Chemistry (1)
Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, N-5021, Norway Department of Pathology, Haukeland University Hospital, Bergen, N-5021, Norway (1)
Clinical Protein Science & Imaging, Biomedical Center, Dept. of Biomedical Engineering, Lund University, Sweden. (1)
Copenhagen University - Novo Nordisk Foundation Center for Protein Research (1)
Medical Biophysics (1)
University of Milan (1)
Department of Innovative Technologies in Medicine and Dentistry,University “G. d’Annunzio” of Chieti-Pescara, Italy (1)
Istituto G. Gaslini (1)
Sichuan University, Westchina Hospital (1)
Department of Pathology and Laboratory Medicine University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA (1)
Head, Department of Anthropology, AISS Amity University Uttar Pradesh Sector-125, Noida (1)
Department for Proteomics, Center for Translational and Clinical Research, School of Medicine, University of Zagreb Department of Anatomy “Drago Perović”, School of Medicine, University of Zagreb (1)

Keyword

Phase I Clinical Trial Candidates (2)
Biomaker (1)
Solid Organ Cancers (1)
Prognostic factors (1)
Pathogenic E.coli (1)
Circulating cell free DNA (1)
Natural History (1)
Tolero (1)
Phase 1a / 1b (1)
First in human (1)
Solid Tumors with immunotherapy progression (1)
AXL inhibitor (1)
Advanced Malignancy (1)
EGFR+ NSCLC with progression on ≤2 lines of oral TKIs (1)
BRAF-Mutated CRC (1)
KRAS-Mutated CRC (1)
NRAS-Mutated CRC (1)
Persistent/Recurrent Ovarian Cancer (1)
BRAF-Mutated Melanoma with immunotherapy progression (1)
Solid Organ Cancer (1)
CRC miRNA (1)
Multi-omics method (1)
Apatinib,bevacizumab,FOLFIRI,colorectal cancer (1)
Molecular Profiling (1)
NGS (1)
Checkpoint inhibitor (1)
Microbiome (1)
Melanoma cancer (1)
Rare cancer (1)
Unknown primary cancer (1)

IsPrivate

False (1)

Submitter Keywords

Machine Learning Model (1)

Study type

Transcription profiling by array (304)
RNA-seq of coding RNA (31)
Methylation profiling by array (29)
Comparative genomic hybridization by array (26)
Proteomic profiling by array (20)
Observational (11)
Unknown experiment type (8)
RNA-seq of non coding RNA (7)
Interventional (7)
Genotyping by array (5)
ChIP-seq (5)
Other (4)
MicroRNA profiling by array (4)
Methylation profiling by high throughput sequencing (4)
Transcription profiling by RT-PCR (3)
ChIP-chip by tiling array (2)
ChIP-chip by array (2)
Observational patient registry (2)
ChIP-chip by SNP array (1)
Transcription profiling by SAGE (1)
High-throughput sequencing (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of total RNA (1)

Release Date

2025 (550)
2022 (492)
2021 (417)
2024 (407)
2023 (382)
2020 (340)
2019 (257)
2018 (186)
2017 (183)
2015 (175)
2014 (173)
2016 (164)
2013 (128)
2012 (112)
2010 (105)
2011 (83)
2026 (71)
2009 (43)
2008 (40)
2007 (20)
2006 (8)
2005 (5)
2004 (2)
2003 (1)
2001 (1)

Location

France (5)
United States (5)
Israel (2)
Canada (2)
China (2)
Spain (2)
New Zealand (1)
Saudi Arabia (1)
Egypt (1)
Poland (1)
Argentina (1)
Australia (1)
Germany (1)
Austria (1)
Japan (1)
Italy (1)
Belgium (1)
Switzerland (1)

Previous page
1 / 528
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 528
Next page

Sort by:

Relevance

Page size

Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most common kidney malignancy. Yet, no rapid, non-invasive biomarkers are available for diagnosis or screening. Urine represents an ideal analyte matrix due to its accessibility, low invasiveness, longitudinal sampling and the kidney’s central role i...

2026-08-16 | MTBLS12025 | MetaboLights

Serum Metabolomics Identifies Novel Prognostic Biomarkers in Amanita Poisoning

Background: Amanita poisoning causes 90-95% of global mushroom-related deaths, yet early prognostic biomarkers for Amanita poisoning are lacking.

Methods: 33 patients with Amanita poisoning were recruited and categorized into survival and death group. Multi...

2025-11-27 | MTBLS13397 | MetaboLights

Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma

Germline or somatic loss-of-function of fumarate hydratase (FH) predisposes patients to an aggressive form of renal cell carcinoma (RCC). Since other than tumor resection, there is no effective therapy for FH-deficient RCC, a competent method for early diagnosis and for early detection of recurre...

2022-08-12 | MTBLS3628 | MetaboLights

Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10-15 yr to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

2023-11-13 | MTBLS1584 | MetaboLights

Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma (Lipidomics)

2026-07-15 | MTBLS14671 | MetaboLights

Tumor Repopulating Cell Transcriptome reveals Specific Cell Surface Biomarkers and Signaling Pathways

PRJNA541001 | ENA

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets

PRJNA483877 | ENA

Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy.

Not available

S-EPMC9702804 | biostudies-literature

Application of blood transcriptomics to identify three novel biomarkers for monitoring anti-TGFbeta therapy

Background: Development of target specific therapeutics greatly benefits from simultaneous identification of biomarkers to determine aspects of bioactivity, drug safety and efficacy or even treatment outcome. This is particularly important when targeting pleiotropic factors such as the TGFbeta syste...

ORGANISM(S): Homo sapiens

2010-07-20 | E-GEOD-15468 | biostudies-arrayexpress

Tumor Tissue-Specific Biomarkers of Colorectal Cancer by Anatomic Location and Stage.

Not available

S-EPMC7345993 | biostudies-literature

Previous page
1 / 528
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 528
Next page

Sort by:

Relevance

Page size

5280 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Submitter Keywords

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets